Business Context and Reporting Period
This Form 6-K filing covers the period ending January 27, 2025, for Mainz Biomed N.V. (noted as "Quantum Cyber N.V." in request metadata, but identified as Mainz Biomed N.V. in the filing text). The registrant is a foreign private issuer headquartered in Mainz, Germany, reporting under Form 20-F.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report is a notification of a corporate governance event rather than a financial results announcement.
Material Changes
- Nasdaq Compliance: The Company announced it has regained compliance with the Nasdaq Capital Market's minimum equity requirement.
- Listing Status: The Company is now in compliance with all Nasdaq listing requirements.
Outlook, Risks, and Management Commentary
Management commentary is limited to the press release incorporated by reference (Exhibit 99.1), which confirms the restoration of listing compliance. The filing does not contain specific forward-looking guidance, new risk factors, or details on unusual items beyond the resolution of the equity deficiency.
Investor Verification Checklist
- Verify the specific equity metrics (e.g., market value of listed securities) that satisfied the Nasdaq minimum equity requirement.
- Review the full text of the press release (Exhibit 99.1) for any additional context on the compliance path.
- Confirm the current stock price and market capitalization to ensure sustained compliance.
- Check for any subsequent filings regarding the Company's financial position, as this 6-K does not include financial statements.